SEC Form 4 insider trading filings tracked in real time from EDGAR

Easom Eric — Chief Executive Officer

Insider trading activity for Easom Eric sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Executive Officer
  • Company: AN2 Therapeutics, Inc.
  • Total insider trades: 6
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Mar 23, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Mar 19, 2026 Easom Eric ANTX AN2 Therapeutics, Inc. SELL 267,650 N/A
Mar 19, 2026 Easom Eric ANTX AN2 Therapeutics, Inc. BUY 267,650 N/A
Mar 19, 2026 Easom Eric ANTX AN2 Therapeutics, Inc. SELL 225,000 N/A
Mar 19, 2026 Easom Eric ANTX AN2 Therapeutics, Inc. BUY 225,000 N/A
Mar 19, 2026 Easom Eric ANTX AN2 Therapeutics, Inc. SELL 249,999 N/A
Mar 19, 2026 Easom Eric ANTX AN2 Therapeutics, Inc. BUY 249,999 N/A

← All executives · Full trades feed